Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Encapsulated retinol may effectively treat actinic keratosis without side effects.

A PEG-400/oleic acid mixture best improves drug delivery monitoring through hair follicles.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

The new patch for treating mouth sores releases medicine slowly, sticks well, and helps healing without the side effects of current creams.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

PPX causes much less hair loss than traditional taxanes.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.